🔎 Trials Near Me

Beranda › Kejang › North Carolina

Uji klinis Kejang di North Carolina

11 studi untuk Kejang mencari peserta di lokasi di North Carolina.

Kota di North Carolina

Teks studi resmi (Bahasa Inggris)

An Efficacy and Safety Study of Clemizole HCl in Patients With Lennox-Gastaut Syndrome

  • Atrium Health STRIVE Research, Charlotte
  • On-Site Clinical Solution, Charlotte
  • Duke University Medical Center, Durham
  • dan 1 lainnya
Menerima pesertaFase 3
Usia 2 hingga 55 · Semua jenis kelamin · Diperbarui 2 Okt 2026 · NCT05066217

A Study to Evaluate the Efficacy and Safety of Cannabidiol Oral Solution (CBD-OS [GWP42003-P, JZP926]) for the Treatment of Focal-Onset Seizures

  • Onsite Clinical Solutions, Charlotte
  • Velocity Clinical Research at Raleigh Neurology, Raleigh
Menerima pesertaFase 1
Usia 12 hingga 75 · Semua jenis kelamin · Diperbarui 2 Okt 2026 · NCT07233239

RENAISSANCE 2: SPN-817 Phase 2, Double-Blind, Placebo-Controlled Study in Adults With Focal Onset Seizures

  • Asheville Neurology Specialists, Asheville
  • OnSite Clinical Solutions, LLC, Charlotte
Menerima pesertaFase 2
Usia 18 hingga 70 · Semua jenis kelamin · Diperbarui 1 Okt 2026 · NCT06798896

Study Evaluating the Efficacy and Safety of RAP-219 in Adult Participants With Focal Seizures FOCUS-1

  • Asheville Neurology Specialists, Asheville
Menerima pesertaFase 3
Usia 18 hingga 75 · Semua jenis kelamin · Diperbarui 1 Okt 2026 · NCT07563881

A Study of EPX-100 (Clemizole Hydrochloride) in Participants With Dravet Syndrome

  • Duke University Health System, Durham
  • Science 37, Morrisville
  • Wake Forest Baptist Medical Center, Winston-Salem
Menerima pesertaFase 3
Usia 2 ke atas · Semua jenis kelamin · Diperbarui 15 Sep 2026 · NCT04462770

Study Evaluating the Efficacy and Safety of RAP-219 in Adult Participants With Focal Seizures

  • Velocity Clinical Research, Raleigh
Menerima pesertaFase 3
Usia 18 hingga 75 · Semua jenis kelamin · Diperbarui 2 Sep 2026 · NCT07594119

Study of NRTX-1001 Neural Cell Therapy in Drug-Resistant Unilateral Mesial Temporal Lobe Epilepsy (EPIC (EPIlepsy Cell Therapy))

  • Atrium Health, Charlotte
  • Duke University Hospital, Durham
  • Atrium Wake Forest Baptist, Winston-Salem
Menerima pesertaFase 3
Usia 18 hingga 75 · Semua jenis kelamin · Diperbarui 9 Jun 2026 · NCT05135091

A Randomized Study of XEN1101 Versus Placebo in Focal-Onset Seizures (X-TOLE3)

  • Duke University Clinic, Durham
Menerima pesertaFase 3
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 14 Mei 2026 · NCT05716100

Oxygen Toxicity: Mechanisms in Humans

  • Duke University Health Sustem, Durham
Menerima pesertaSukarelawan sehat diterima
Usia 18 hingga 45 · Semua jenis kelamin · Diperbarui 23 Okt 2025 · NCT05761756

Pediatric Dose Optimization for Seizures in Emergency Medical Services

  • Mecklenburg EMS, Charlotte
Menerima pesertaFase 3
6 Months – 13 Years · Semua jenis kelamin · Diperbarui 30 Sep 2025 · NCT05121324

Investigate Efficacy and Safety of Carisbamate as Adjunctive Treatment for Seizures Associated With LGS in Children and Adults

  • Duke University Clinical Research at Pickett Road, Durham
Menerima pesertaFase 3
Usia 4 hingga 55 · Semua jenis kelamin · Diperbarui 24 Jul 2025 · NCT05219617

Dari ClinicalTrials.gov, data diambil 5 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.